Extracellular HMGB1: a therapeutic target in severe pulmonary inflammation including COVID-19?
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Extracellular HMGB1: a therapeutic target in severe pulmonary inflammation including COVID-19?
Authors
Keywords
-
Journal
MOLECULAR MEDICINE
Volume 26, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-05-07
DOI
10.1186/s10020-020-00172-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- RSV Infection Promotes Necroptosis and HMGB1 Release by Airway Epithelial Cells
- (2020) Jennifer Simpson et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- The role of type 1 interferons in Gram-negative bacteria-induced coagulation
- (2020) Xinyu Yang et al. BLOOD
- The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak
- (2020) Hussin A. Rothan et al. JOURNAL OF AUTOIMMUNITY
- Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
- (2020) Roujian Lu et al. LANCET
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2
- (2020) Renhong Yan et al. SCIENCE
- What we know so far: COVID-19 current clinical knowledge and research
- (2020) Mary A Lake CLINICAL MEDICINE
- Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
- (2020) Philippe Gautret et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Sex-specific stress response and HMGB1 release in pulmonary endothelial cells
- (2020) Marina Zemskova et al. PLoS One
- Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies
- (2020) Jianjun Gao et al. BioScience Trends
- Downregulation of Lysosomal Acid Ceramidase Mediates HMGB1-Induced Migration and Proliferation of Mouse Coronary Arterial Myocytes
- (2020) Xinxu Yuan et al. Frontiers in Cell and Developmental Biology
- Recombinant Human Soluble Thrombomodulin in Sepsis-Induced Coagulopathy: An Updated Systematic Review and Meta-Analysis
- (2019) Shuhei Murao et al. THROMBOSIS AND HAEMOSTASIS
- Anti-HMGB1 monoclonal antibody therapy for a wide range of CNS and PNS diseases
- (2019) Masahiro Nishibori et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Inhibition of HMGB1/RAGE-mediated endocytosis by HMGB1 antagonist box A, anti-HMGB1 antibodies, and cholinergic agonists suppresses inflammation
- (2019) Huan Yang et al. MOLECULAR MEDICINE
- Heparinoid sevuparin inhibits Streptococcus-induced vascular leak through neutralizing neutrophil-derived proteins
- (2019) Joel Rasmuson et al. FASEB JOURNAL
- Serum high-mobility group box 1 is correlated with interferon-α and may predict disease activity in patients with systemic lupus erythematosus
- (2019) A Tanaka et al. LUPUS
- Biphasic Release of the Alarmin High Mobility Group Box 1 Protein Early After Trauma Predicts Poor Clinical Outcome
- (2019) William Ottestad et al. CRITICAL CARE MEDICINE
- SIRT1-regulated HMGB1 release is partially involved in TLR4 signal transduction: A possible anti-neuroinflammatory mechanism of resveratrol in neonatal hypoxic-ischemic brain injury
- (2019) Kai Le et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Dexmedetomidine-mediated protection against septic liver injury depends on TLR4/MyD88/NF-κB signaling downregulation partly via cholinergic anti-inflammatory mechanisms
- (2019) Shuang-feng Zi et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Endothelial cell pyroptosis plays an important role in Kawasaki disease via HMGB1/RAGE/cathespin B signaling pathway and NLRP3 inflammasome activation
- (2019) Chang Jia et al. Cell Death & Disease
- Bacterial Endotoxin Activates the Coagulation Cascade through Gasdermin D-Dependent Phosphatidylserine Exposure
- (2019) Xinyu Yang et al. IMMUNITY
- HMGB1 concentration measurements in trauma patients: assessment of pre-analytical conditions and sample material
- (2019) William Ottestad et al. MOLECULAR MEDICINE
- Molecular and Functional Neuroscience in Immunity
- (2018) Valentin A. Pavlov et al. Annual Review of Immunology
- Extracellular HMGB1 as a therapeutic target in inflammatory diseases
- (2018) Ulf Andersson et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Anti-high mobility group box-1 monoclonal antibody treatment of brain edema induced by influenza infection and lipopolysaccharide
- (2018) Nobuyuki Nosaka et al. JOURNAL OF MEDICAL VIROLOGY
- The protective effect of dexmedetomidine on LPS-induced acute lung injury through the HMGB1-mediated TLR4/NF-κB and PI3K/Akt/mTOR pathways
- (2018) Lu Meng et al. MOLECULAR IMMUNOLOGY
- Induction of high-mobility group Box-1 in vitro and in vivo by respiratory syncytial virus
- (2018) Sara Manti et al. PEDIATRIC RESEARCH
- High-mobility group box 1 protein (HMGB1) operates as an alarmin outside as well as inside cells
- (2018) Ulf Andersson et al. SEMINARS IN IMMUNOLOGY
- The Pathogenic Involvement of Neutrophils in Acute Respiratory Distress Syndrome and Transfusion-Related Acute Lung Injury
- (2018) Johan Rebetz et al. TRANSFUSION MEDICINE AND HEMOTHERAPY
- HMGB1: A Common Biomarker and Potential Target for TBI, Neuroinflammation, Epilepsy, and Cognitive Dysfunction
- (2018) Yam Nath Paudel et al. Frontiers in Neuroscience
- The Endotoxin Delivery Protein HMGB1 Mediates Caspase-11-Dependent Lethality in Sepsis
- (2018) Meihong Deng et al. IMMUNITY
- Proinflammatory Effects of Respiratory Syncytial Virus–Induced Epithelial HMGB1 on Human Innate Immune Cell Activation
- (2018) Kempaiah Rayavara et al. JOURNAL OF IMMUNOLOGY
- Combined effect of anti-high-mobility group box-1 monoclonal antibody and peramivir against influenza A virus-induced pneumonia in mice
- (2018) Kazuki Hatayama et al. JOURNAL OF MEDICAL VIROLOGY
- Non-invasive transcutaneous auricular vagus nerve stimulation prevents postoperative ileus and endotoxemia in mice
- (2018) Gun-Soo Hong et al. NEUROGASTROENTEROLOGY AND MOTILITY
- DNA-Mediated Interferon Signature Induction by SLE Serum Occurs in Monocytes Through Two Pathways: A Mechanism to Inhibit Both Pathways
- (2018) Amit Porat et al. Frontiers in Immunology
- AIM2 Inflammasome Is Critical for Influenza-Induced Lung Injury and Mortality
- (2017) Hongbo Zhang et al. JOURNAL OF IMMUNOLOGY
- Influenza
- (2017) Catharine Paules et al. LANCET
- Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study
- (2017) Ting Shi et al. LANCET
- Circulating level of high mobility group box-1 predicts the severity of community-acquired pneumonia: Regulation of inflammatory responses via the c-Jun N-terminal signaling pathway in macrophages
- (2017) Hsiang-Ling Wang et al. Molecular Medicine Reports
- Inhibition of merozoite invasion and transient de-sequestration by sevuparin in humans with Plasmodium falciparum malaria
- (2017) Anna M. Leitgeb et al. PLoS One
- A novel high mobility group box 1 neutralizing chimeric antibody attenuates drug-induced liver injury and postinjury inflammation in mice
- (2016) Peter Lundbäck et al. HEPATOLOGY
- Ketamine attenuates sepsis-induced acute lung injury via regulation of HMGB1-RAGE pathways
- (2016) Kehan Li et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Statin protects endothelial cell against ischemia reperfusion injury through HMGB1/TLR4 pathway
- (2016) Zhaowei Zhu et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- High-mobility group box 1 impairs airway epithelial barrier function through the activation of the RAGE/ERK pathway
- (2016) WUFENG HUANG et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Frontline Science: HMGB1 induces neutrophil dysfunction in experimental sepsis and in patients who survive septic shock
- (2016) Murielle Grégoire et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Novel strategies for targeting innate immune responses to influenza
- (2016) K A Shirey et al. Mucosal Immunology
- Chronic vagus nerve stimulation in Crohn's disease: a 6-month follow-up pilot study
- (2016) B. Bonaz et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Vagus nerve stimulation inhibits cytokine production and attenuates disease severity in rheumatoid arthritis
- (2016) Frieda A. Koopman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hemorrhagic shock primes for lung vascular endothelial cell pyroptosis: role in pulmonary inflammation following LPS
- (2016) Jie Yang et al. Cell Death & Disease
- Stress sounds the alarmin: The role of the danger-associated molecular pattern HMGB1 in stress-induced neuroinflammatory priming
- (2015) Matthew G. Frank et al. BRAIN BEHAVIOR AND IMMUNITY
- Heparin inhibits the inflammatory response induced by LPS and HMGB1 by blocking the binding of HMGB1 to the surface of macrophages
- (2015) Li Li et al. CYTOKINE
- Thrombomodulin as an intravascular safeguard against inflammatory and thrombotic diseases
- (2015) Takashi Ito et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Simvastatin protects the heart against ischemia reperfusion injury via inhibiting HMGB1 expression through PI3K/Akt signal pathways
- (2015) Qian-Feng Han et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- MD-2 is required for disulfide HMGB1–dependent TLR4 signaling
- (2015) Huan Yang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Intestinal Epithelial TLR-4 Activation Is Required for the Development of Acute Lung Injury after Trauma/Hemorrhagic Shock via the Release of HMGB1 from the Gut
- (2015) Chhinder P. Sodhi et al. JOURNAL OF IMMUNOLOGY
- 2-O, 3-O-Desulfated Heparin Inhibits Neutrophil Elastase–Induced HMGB-1 Secretion and Airway Inflammation
- (2014) Kathryn L. Griffin et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Macrophage endocytosis of high-mobility group box 1 triggers pyroptosis
- (2014) J Xu et al. CELL DEATH AND DIFFERENTIATION
- Resveratrol Reduces the Proinflammatory Effects and Lipopolysaccharide- Induced Expression of HMGB1 and TLR4 in RAW264.7 Cells
- (2014) Ying Yang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Impact of Serum Biomarkers and Clinical Factors on Intensive Care Unit Mortality and 6-Month Outcome in Relatively Healthy Patients with Severe Pneumonia and Acute Respiratory Distress Syndrome
- (2014) Chia-Cheng Tseng et al. DISEASE MARKERS
- Dexmedetomidine Controls Systemic Cytokine Levels through the Cholinergic Anti-inflammatory Pathway
- (2014) Hui Xiang et al. INFLAMMATION
- Ketamine inhibits LPS-induced HGMB1 release in vitro and in vivo
- (2014) Zhaohang Zhang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- The HMGB1/RAGE axis triggers neutrophil-mediated injury amplification following necrosis
- (2014) Peter Huebener et al. JOURNAL OF CLINICAL INVESTIGATION
- HMGB1 Develops Enhanced Proinflammatory Activity by Binding to Cytokines
- (2014) Y. Sha et al. JOURNAL OF IMMUNOLOGY
- HMGB1 in health and disease
- (2014) Rui Kang et al. MOLECULAR ASPECTS OF MEDICINE
- JAK/STAT1 signaling promotes HMGB1 hyperacetylation and nuclear translocation
- (2014) B. Lu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inhibition of extracellular HMGB1 attenuates hyperoxia-induced inflammatory acute lung injury
- (2014) Maria Entezari et al. Redox Biology
- Simvastatin suppresses vascular inflammation and atherosclerosis in ApoE−/− mice by downregulating the HMGB1-RAGE axis
- (2013) Ming Liu et al. ACTA PHARMACOLOGICA SINICA
- Short-time pretreatment of rosuvastatin attenuates myocardial ischemia and reperfusion injury by inhibiting high mobility group box 1 protein expression
- (2013) Bing Wu et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Partially-desulfated heparin improves survival inPseudomonaspneumonia by enhancing bacterial clearance and ameliorating lung injury
- (2013) Lokesh Sharma et al. Journal of Immunotoxicology
- The TLR4 antagonist Eritoran protects mice from lethal influenza infection
- (2013) Kari Ann Shirey et al. NATURE
- An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies
- (2013) Domenica Musumeci et al. PHARMACOLOGY & THERAPEUTICS
- Anti-high mobility group box-1 antibody therapy for traumatic brain injury
- (2012) Yu Okuma et al. ANNALS OF NEUROLOGY
- Neural reflexes in inflammation and immunity
- (2012) Ulf Andersson et al. JOURNAL OF EXPERIMENTAL MEDICINE
- HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4
- (2012) Milena Schiraldi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Unknown
- (2012) Maria Entezari et al. MOLECULAR MEDICINE
- Systemic Involvement of High-Mobility Group Box 1 Protein and Therapeutic Effect of Anti–High-Mobility Group Box 1 Protein Antibody in a Rat Model of Crush Injury
- (2012) Junya Shimazaki et al. SHOCK
- Respiratory Syncytial Virus Fusion Protein-Induced Toll-Like Receptor 4 (TLR4) Signaling Is Inhibited by the TLR4 Antagonists Rhodobacter sphaeroides Lipopolysaccharide and Eritoran (E5564) and Requires Direct Interaction with MD-2
- (2012) P. Rallabhandi et al. mBio
- HMGB1 Is a Therapeutic Target for Sterile Inflammation and Infection
- (2011) Ulf Andersson et al. Annual Review of Immunology
- Increased levels of cytokines and high-mobility group box 1 are associated with the development of severe pneumonia, but not acute encephalopathy, in 2009 H1N1 influenza-infected children
- (2011) Yoshinori Ito et al. CYTOKINE
- Glycyrrhizin Exerts Antioxidative Effects in H5N1 Influenza A Virus-Infected Cells and Inhibits Virus Replication and Pro-Inflammatory Gene Expression
- (2011) Martin Michaelis et al. PLoS One
- High mobility group box protein 1 in complex with lipopolysaccharide or IL-1 promotes an increased inflammatory phenotype in synovial fibroblasts
- (2011) Heidi Wähämaa et al. ARTHRITIS RESEARCH & THERAPY
- Heparin changes the conformation of high-mobility group protein 1 and decreases its affinity toward receptor for advanced glycation endproducts in vitro
- (2010) Yan Ling et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Protective Effects of Dexmedetomidine-Ketamine Combination Against Ventilator-Induced Lung Injury in Endotoxemia Rats
- (2010) Chih-Lin Yang et al. JOURNAL OF SURGICAL RESEARCH
- Glycyrrhizin inhibits highly pathogenic H5N1 influenza A virus-induced pro-inflammatory cytokine and chemokine expression in human macrophages
- (2010) Martin Michaelis et al. MEDICAL MICROBIOLOGY AND IMMUNOLOGY
- Unknown
- (2010) Hanna Schierbeck et al. MOLECULAR MEDICINE
- A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release
- (2010) H. Yang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation
- (2009) Hulda Sigridur Hreggvidsdottir et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Novel signaling interactions between proteinase-activated receptor 2 and Toll-like receptors in vitro and in vivo
- (2009) Q M Nhu et al. Mucosal Immunology
- PULMONARY LEVELS OF HIGH-MOBILITY GROUP BOX 1 DURING MECHANICAL VENTILATION AND VENTILATOR-ASSOCIATED PNEUMONIA
- (2009) Marieke A.D. van Zoelen et al. SHOCK
- Receptor for advanced glycation end products is detrimental during influenza A virus pneumonia
- (2009) Marieke A.D van Zoelen et al. VIROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More